Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT06207812

Conditions

Lymphomatoid Papulosis

Mycosis Fungoides

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

To follow up with all our participants with juvenile-onset mycosis fungoides, check on their status, and ask them or their parents about long term outcomes associated with their condition.

Conditions

Lymphomatoid Papulosis

Mycosis Fungoides

Study ID

NCT06207812

Start date

Jan 19, 2024

Status verified date

Jul, 2026

Completion date

Jan 12, 2028

Anticipated

Primary completion date

Jan 12, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

-To be eligible, participants had to be diagnosed with jMF or lyp before age 20. In the case of participants below the age of 18, parents and not the children will be contacted for participation (children are exempt from participation as their parents may answer our study questions).

Exclusion Criteria:

-Participants older than 20 years of age at diagnosis

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Safety and adverse events (AEs) [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts and Locations

Central contacts

Julia Dai, MD

(713) 515-7961jdai6@mdanderson.org

Locations

MD Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Julia Dai, MD

713-515-7961jdai6@mdanderson.org

Principal Investigator:

Julia Dai, MD

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Jul 16, 2026

Last verified

Jul, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-07-16.